According to Transgene SA's latest financial reports the company's current EPS (TTM) is -โน206.15. In 2022 the company made an earnings per share (EPS) of -โน30.31 a decrease over its 2021 EPS that were of -โน20.45.
Year | EPS | Change |
---|---|---|
2022 | -โน30.31 | 48.16% |
2021 | -โน20.45 | -6.93% |
2020 | -โน21.98 | -0.6% |
2019 | -โน22.11 | -273.41% |
2018 | โน12.75 | -124.48% |
2017 | -โน52.08 | 31.82% |
2016 | -โน39.51 | -63.87% |
2015 | -โน109.35 | -14.59% |
2014 | -โน128.03 | -17.15% |
2013 | -โน154.53 | 2.99% |
2012 | -โน150.04 | 0.3% |
2011 | -โน149.59 | 8.93% |
2010 | -โน137.33 | -7.32% |
2009 | -โน148.18 | 56.96% |
2008 | -โน94.41 | 176.84% |
2007 | -โน34.10 | -77.81% |
2006 | -โน153.70 | 42.51% |
2005 (TTM) | -โน107.85 | -57.67% |
2004 | -โน254.80 | 18.71% |
2003 | -โน214.64 | 35.08% |
2002 | -โน158.90 | -16.55% |
2001 | -โน190.42 | -37.1% |
2000 | -โน302.74 | 13.45% |
1999 | -โน266.84 | -60.26% |
1998 | -โน671.52 | 109.21% |
1997 | -โน320.97 |